CRM stock forecast

**Quick verdict 🏁✨** Salesforce (CRM) is still pointed toward a **bullish drift**, with our trend-similarity model projecting a mean price of **$205.21 on 16 Mar 2026** and a potential **+50.37 % upside versus –31.75 % downside** over the next few months. Near-term, the stock is digesting a $25 B bond deal and mixed analyst chatter, so expect choppy trading until the next earnings print in late February 2026. 📈🔍 --- ### 1. Where the chart stands today 📊 • CRM closed at **$192.83 on 13 Mar 2026**, slipping 3.24 % on the day. • The SAR-based channel model flashes **“Bearish / Sell”** with price sitting **below its wide support band**. • Yet the broader trend window shows a **Bullish** outlook, suggesting the current pullback may be a pause rather than a trend reversal. 🔄⚖️ |market_code|code|Ticker|Name|Date|Closing Price| |---|---|---|---|---|---| |169|CRM|CRM.N|Salesforce|20260312|199.28| --- ### 2. Fundamental tailwinds you can bank on 💰 • **Earnings momentum:** Q4 EPS of **$3.81 beat** the $3.05 consensus, and FY-27 guidance of **$13.11–13.19 EPS** keeps the growth story intact. • **AI & Agentforce rollout:** Management says AI is “improving all of our products,” underpinning the FY-27 revenue target of **$46.2 B**. • **Shareholder-friendly capital moves:** A $25 B senior-note offering funds buybacks, while the quarterly dividend was lifted to **$0.44** (0.9 % yield). 🚀💵 --- ### 3. Valuation & sentiment check 🧐 | Metric | Latest | Takeaway | |--------|--------|----------| | P/E (TTM) | **23.87** | Reasonable for a high-growth SaaS name | | PEG | **0.58** | Suggests growth is undervalued | | Institutional ownership | **51.26 % float** | Deep pockets backing the story | | Analyst stance | “Moderate Buy”, avg. target **$282.06** | Street still sees 45 %+ upside | |market_code|code|Ticker|Name|Date|P/E(TTM)| |---|---|---|---|---|---| |169|CRM|CRM.N|Salesforce|20250314|43.327965| |169|CRM|CRM.N|Salesforce|20250317|43.537316| |169|CRM|CRM.N|Salesforce|20250318|43.224064| |169|CRM|CRM.N|Salesforce|20250319|43.326414| |169|CRM|CRM.N|Salesforce|20250320|43.270587| |169|CRM|CRM.N|Salesforce|20250321|43.517156| |169|CRM|CRM.N|Salesforce|20250324|44.345257| |169|CRM|CRM.N|Salesforce|20250325|44.756206| |169|CRM|CRM.N|Salesforce|20250326|43.574534| |169|CRM|CRM.N|Salesforce|20250327|43.081395| |market_code|code|Ticker|Name|Date|Institutional Position Ratio| |---|---|---|---|---|---| |169|CRM|CRM.N|Salesforce|20250314|80.9787| |169|CRM|CRM.N|Salesforce|20250317|80.9817| |169|CRM|CRM.N|Salesforce|20250318|80.9823| |169|CRM|CRM.N|Salesforce|20250319|80.9834| |169|CRM|CRM.N|Salesforce|20250320|80.9834| |169|CRM|CRM.N|Salesforce|20250321|80.984| |169|CRM|CRM.N|Salesforce|20250324|80.9844| |169|CRM|CRM.N|Salesforce|20250325|80.9844| |169|CRM|CRM.N|Salesforce|20250326|80.9844| |169|CRM|CRM.N|Salesforce|20250327|80.9844| --- ### 4. What could go wrong? ⚠️ 1. **Bond-yield pushback:** Investors demanded higher coupons on the $25 B notes, stoking worries about leverage and AI execution risk. 2. **Analyst downgrades:** Northland, DA Davidson, and others trimmed targets to the $200–230 zone, adding near-term selling pressure. 3. **Technical headwinds:** Eight-day bearish streak and SAR “Sell” signal could invite further profit-taking before the next catalyst. 🌪️ --- ### 5. Actionable game-plan 🛠️ • **Accumulation zone:** Consider nibbling between $185–$195, where the trend-similarity model shows a higher probability of support. • **Trim into strength:** If shares revisit the $220–$230 resistance band, lock in partial gains to manage volatility. • **Catalyst watch:** – Next earnings (25 Feb 2026) for confirmation of FY-27 guide. – Any update on buyback cadence—execution could be a near-term price kicker. 📅💡 --- **Curious thought to ponder 🤔:** If CRM’s PEG ratio keeps defying the SaaS pack, would you feel more comfortable *adding* on weakness—or would you rather wait for the next earnings call to confirm the AI-driven margin story? 🎯💬